Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation

A 10-year experience of the Okayama BMT Group

Nobuharu Fujii, Koichi Nakase, Shoji Asakura, Keitaro Matsuo, Yuichiro Nawa, Kazutaka Sunami, Hisakazu Nishimori, Ken-ichi Matsuoka, Eisei Kondo, Yoshinobu Maeda, Katsuji Shinagawa, Masamichi Hara, Mitsune Tanimoto

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bronchiolitis obliterans (BO) is a devastating complication of allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively studied 465 patients who underwent HSCT in the Okayama BMT Group between 2000 and 2009, and describe the detailed clinical features of 13 patients with BO. The 5-year cumulative incidence of BO was 3.43 %. The median time from transplantation to onset of BO was 15 months. In seven of the 13 patients, the primary symptom was only cough, indicating that cough was an important initial symptom for early diagnosis. The median duration from the onset of BO to the requirement of O 2 supplementation was 13 months and the main cause of death was respiratory failure. History of chronic graft-versus-host disease was a significant risk factor. Furthermore, female recipients were at greater risk of BO than male recipients; however, no other previously reported risk factors were detected. It is currently difficult to prevent BO on the basis of the reported risk factors. A novel strategy for the early diagnosis and treatment of BO is required.

Original languageEnglish
Pages (from-to)644-651
Number of pages8
JournalInternational Journal of Hematology
Volume99
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Bronchiolitis Obliterans
antineoplaston A10
Cell Transplantation
Hematopoietic Stem Cell Transplantation
Cough
Early Diagnosis
Graft vs Host Disease
Respiratory Insufficiency
Cause of Death
Transplantation
Incidence

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Bronchiolitis obliterans
  • Chronic graft-versus-host disease

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation : A 10-year experience of the Okayama BMT Group. / Fujii, Nobuharu; Nakase, Koichi; Asakura, Shoji; Matsuo, Keitaro; Nawa, Yuichiro; Sunami, Kazutaka; Nishimori, Hisakazu; Matsuoka, Ken-ichi; Kondo, Eisei; Maeda, Yoshinobu; Shinagawa, Katsuji; Hara, Masamichi; Tanimoto, Mitsune.

In: International Journal of Hematology, Vol. 99, No. 5, 2014, p. 644-651.

Research output: Contribution to journalArticle

Fujii, Nobuharu ; Nakase, Koichi ; Asakura, Shoji ; Matsuo, Keitaro ; Nawa, Yuichiro ; Sunami, Kazutaka ; Nishimori, Hisakazu ; Matsuoka, Ken-ichi ; Kondo, Eisei ; Maeda, Yoshinobu ; Shinagawa, Katsuji ; Hara, Masamichi ; Tanimoto, Mitsune. / Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation : A 10-year experience of the Okayama BMT Group. In: International Journal of Hematology. 2014 ; Vol. 99, No. 5. pp. 644-651.
@article{765f1937c77e4870831027ded86f2b39,
title = "Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: A 10-year experience of the Okayama BMT Group",
abstract = "Bronchiolitis obliterans (BO) is a devastating complication of allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively studied 465 patients who underwent HSCT in the Okayama BMT Group between 2000 and 2009, and describe the detailed clinical features of 13 patients with BO. The 5-year cumulative incidence of BO was 3.43 {\%}. The median time from transplantation to onset of BO was 15 months. In seven of the 13 patients, the primary symptom was only cough, indicating that cough was an important initial symptom for early diagnosis. The median duration from the onset of BO to the requirement of O 2 supplementation was 13 months and the main cause of death was respiratory failure. History of chronic graft-versus-host disease was a significant risk factor. Furthermore, female recipients were at greater risk of BO than male recipients; however, no other previously reported risk factors were detected. It is currently difficult to prevent BO on the basis of the reported risk factors. A novel strategy for the early diagnosis and treatment of BO is required.",
keywords = "Allogeneic hematopoietic cell transplantation, Bronchiolitis obliterans, Chronic graft-versus-host disease",
author = "Nobuharu Fujii and Koichi Nakase and Shoji Asakura and Keitaro Matsuo and Yuichiro Nawa and Kazutaka Sunami and Hisakazu Nishimori and Ken-ichi Matsuoka and Eisei Kondo and Yoshinobu Maeda and Katsuji Shinagawa and Masamichi Hara and Mitsune Tanimoto",
year = "2014",
doi = "10.1007/s12185-014-1556-4",
language = "English",
volume = "99",
pages = "644--651",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation

T2 - A 10-year experience of the Okayama BMT Group

AU - Fujii, Nobuharu

AU - Nakase, Koichi

AU - Asakura, Shoji

AU - Matsuo, Keitaro

AU - Nawa, Yuichiro

AU - Sunami, Kazutaka

AU - Nishimori, Hisakazu

AU - Matsuoka, Ken-ichi

AU - Kondo, Eisei

AU - Maeda, Yoshinobu

AU - Shinagawa, Katsuji

AU - Hara, Masamichi

AU - Tanimoto, Mitsune

PY - 2014

Y1 - 2014

N2 - Bronchiolitis obliterans (BO) is a devastating complication of allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively studied 465 patients who underwent HSCT in the Okayama BMT Group between 2000 and 2009, and describe the detailed clinical features of 13 patients with BO. The 5-year cumulative incidence of BO was 3.43 %. The median time from transplantation to onset of BO was 15 months. In seven of the 13 patients, the primary symptom was only cough, indicating that cough was an important initial symptom for early diagnosis. The median duration from the onset of BO to the requirement of O 2 supplementation was 13 months and the main cause of death was respiratory failure. History of chronic graft-versus-host disease was a significant risk factor. Furthermore, female recipients were at greater risk of BO than male recipients; however, no other previously reported risk factors were detected. It is currently difficult to prevent BO on the basis of the reported risk factors. A novel strategy for the early diagnosis and treatment of BO is required.

AB - Bronchiolitis obliterans (BO) is a devastating complication of allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively studied 465 patients who underwent HSCT in the Okayama BMT Group between 2000 and 2009, and describe the detailed clinical features of 13 patients with BO. The 5-year cumulative incidence of BO was 3.43 %. The median time from transplantation to onset of BO was 15 months. In seven of the 13 patients, the primary symptom was only cough, indicating that cough was an important initial symptom for early diagnosis. The median duration from the onset of BO to the requirement of O 2 supplementation was 13 months and the main cause of death was respiratory failure. History of chronic graft-versus-host disease was a significant risk factor. Furthermore, female recipients were at greater risk of BO than male recipients; however, no other previously reported risk factors were detected. It is currently difficult to prevent BO on the basis of the reported risk factors. A novel strategy for the early diagnosis and treatment of BO is required.

KW - Allogeneic hematopoietic cell transplantation

KW - Bronchiolitis obliterans

KW - Chronic graft-versus-host disease

UR - http://www.scopus.com/inward/record.url?scp=84901607455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901607455&partnerID=8YFLogxK

U2 - 10.1007/s12185-014-1556-4

DO - 10.1007/s12185-014-1556-4

M3 - Article

VL - 99

SP - 644

EP - 651

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 5

ER -